Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

Patients with Unruptured IntraCranial ANeurysms: Evaluation of the Benefits of Allied Health FollOw-uP in a RandomizEd Controlled Trial

A legfontosabb adatok

Ki végzi
Nantes University Hospital
Hol
Franciaország1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
340 fő, tervezett
Kezdés
2023. nov. 7.
Várható befejezés
2028. máj. 6.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport nem kap vizsgálati kezelést, összehasonlításként.
A vizsgált kezelések
  • Follow-up according to the Canhope allied health support program
A regiszteradat frissítve
2024. november 27.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with a recently found brain aneurysm (a bulge in a brain blood vessel) that has not burst. The aneurysm must be untreated and watched with scans. The trial tests a support program run by nurses and other health staff.

Életkor
Over 18
Nem
All sexes
A betegség stádiuma
Intracranial aneurysm found less than 9 months ago. It has not burst, has not been treated, and is watched with imaging scans.
Korábbi kezelés
The aneurysm must not have been treated.

A részvétel fő kizáró okai

  • Past burst (ruptured) brain aneurysm
  • Under guardianship or curatorship
  • A syndrome known to cause brain aneurysms, such as Marfan syndrome, AOS with SMAD 3 mutations, type II or IV Elhers Danlos syndrome, autosomal dominant polycystic fibrosis or Moya-Moya syndrome
  • Dissecting, fusiform, blister-like or mycotic aneurysm
  • Aneurysm linked to an arteriovenous malformation (a tangle of abnormal blood vessels)

A regiszter feltételei, szó szerint

Mind a 8 feltétel megnézéseKevesebb

Ki vehet részt

  • Patient with newly diagnosed (<9 months) untreated Intracranial Aneurysm
  • Patient with untreated Intracranial Aneurysm monitored by imaging
  • Patient over 18
  • Patient agreeing to participate in the study and having signed the consent form

Ki nem vehet részt

  • Patient with a history of ruptured Intracranial Aneurysm
  • Patient diagnosed with a syndrome known to cause Intracranial Aneurysm :; Marfan syndrome; AOS (Aneurysm Osteoarthritis Syndrome) with SMAD 3 mutations; Type II and IV Elhers Danlos syndrome; Autosomal dominant polycystic fibrosis; Moya-Moya syndrome
  • Patient under guardianship or curatorship
  • Patient with:; Dissecting or fusiform Intracranial Aneurysm; Intracranial Aneurysm associated with an arteriovenous malformation; Blister-like Intracranial Aneurysm; Mycotic Intracranial Aneurysm

Ez a vizsgálat jelenleg itt érhető el: Franciaország.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

The CANHOPE study falls within the scope of research on patients' experiences and the improvement of their management through interventions meeting their needs.

A teljes eredeti leírásKevesebb

The study protocol assesses a support program for patients with untreated intracranial aneurysms (ICAs), for whom several sources of data converge in describing inadequacies in patients' care pathway and a deleterious impact on their health.

The initial questioning is based on the practice of caregivers, who are witnesses of patients' feelings during ICA follow-up and are sometimes unable to support them due to a lack of knowledge about the impact of the disease and an organization that does not provide any space dedicated to their support.

The study topic described below explains the medical context of ICA, and the data available in the literature on the impact of this condition on patients' lives. These data are complemented by the results of a qualitative study recently conducted in Nantes University Hospital in 10 subjects who participated in two focus groups. The discussions have revealed many areas of tension related to the management of uncertainty: "questions arise after the consultation"; "there should be an ALLO INFO ANEURYSM number"; "if it ruptures, it's over, that's what I've understood"; "I fall asleep every night thinking it might be the last time". The need for specific support, particularly during the first year, appears to be obvious.

Based on these experiences, it has been hypothesized that an allied health follow-up of patients managed by simple monitoring, focused on the management of uncertainty, during the first year following the announcement, could reduce anxiety and improve patients' quality of life.

Inspired by participants' experiences and guided by the uncertainty in illness theory, the study is focused on proposing an allied health management organized around items known to sustain patients' hope.

The aim of the CANHOPE study is therefore to assess the CANHOPE program, in order to provide clinicians and decision-makers with the data they need to support the implementation of this program in referral centers for ICA follow-up. This study will be conducted in two parallel parts: 1/ a multicenter, cluster, randomized, controlled trial and 2/ a comprehensive qualitative study.

A vizsgálat 2 csoportja

  • Canhope follow-upA vizsgált kezelés

    Day 0: Post-announcement interview with allied health professionals (information and support interview) and then between Day 7 and Day 14, phone call (support relationship, answers to questions), followed by a hotline dedicated to questions. Between month 3 and month 10: patient focus group.

    Kezelés: Follow-up according to the Canhope allied health support program

  • Usual CareNincs vizsgálati kezelés, összehasonlításként

    Announcement of a management by the neuroradiologist and frequency of imaging follow-up, information media

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2024. november 27.